Skip to main content
Update
Non-financial boards have been closed.

Non-financial boards have been closed but will continue to be accessible in read-only form. If you're disappointed, we understand. Thank you for being an active participant in this community. We have more community features in development that we look forward to sharing soon.

Fool.com | The Motley Fool Community
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2
Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s stalled Build Back Better plan — the proposal to cap insulin costs at $35 a month.

It might not go well.

That’s true even though the idea of helping millions of Americans with diabetes afford a crucial medicine has immense public support and even bipartisan adherents. But then, there is politics — between Democrats and Republicans, of course, but also among Democrats.

https://www.ajc.com/life/health/35-insulin-cap-is-popular-an...

Fuskie
Who generally tries to stay away from politics on the boards, but he guesses that this issue is as personal for many other Fools as it is for him, so he would encourage everyone to contact their representatives and urge them to make this happen, no matter the political path it takes...

-----
Premium Home Fool: Ask me a Foolish Question, I'll give you a Foolish Response!
Ticker Guide: The Walt Disney Company (DIS), Intuit (INTU), Live Nation (LYV), CME Group (CME), MongoDB (MDB), Trip Advisor (TRIP), Vivendi SA (VIVHY), Mimecast (MIME), Virgin Galactic (SPCE), Axon Technologies (AXON), 51Jobs (JOBS)
Disclaimer: This post is non-professional and should not be construed as direct, individual or accurate advice
Disassociation: The views and statements of this post are Fuskie's and are not intended to represent those of The Motley Fool or any other sane body
Disclosure: May own shares of some, many or all of the companies mentioned in this post: https://tinyurl.com/FuskieDisclosure
Fool Code of Conduct: https://www.fool.com/legal/the-motley-fools-rules.aspx#Condu...
Invitation: You are invited to interactively watch Motley Fool Live online television: https://www.fool.com/premium/live/
Call to Action: If you like this or any other post, Rec it. Better yet, reply to it. Even better, start your own thread. This is YOUR TMF Community!
Print the post Back To Top
No. of Recommendations: 0
If Civica can do what it claims, and even get close on their proposed price, that will crash the marketplace for fast-acting insulin.

Basal products such as Lantus, Basaglar, etc will take longer. Lantus is no longer protected by patents, but the production requirements are, as yet, not really known except to the companies.

Trulicity, etc would be much longer still because they do fill a niche fast-acting insulin can not. And this class of drugs would have significant production costs even if there were no patents.
Print the post Back To Top
No. of Recommendations: 0
i started trulicity about 10 months ago...almost $500.00 every 3 months out of pocket...i have not got enough evidence that it does me any good
Print the post Back To Top
No. of Recommendations: 0
i started trulicity about 10 months ago...almost $500.00 every 3 months out of pocket...i have not got enough evidence that it does me any good

I use it and get noticeable results. Dosage recently adjusted upward as that is what it took to get things generally back to "should be".
Print the post Back To Top